Computational studies of the binding modes of CCR1 antagonists

References

• Baggiolini , M. 1998 . Chemokines and leukocyte traffic . Nature , 392 : 565 – 568 .
   PubMed Web of Science ®Google Scholar
• Strieter , R.M. , Standiford , T.J. , Huffnagle , G.B. , Colletti , L.M. , Lukacs , N.W. and Kunkel , S.L. 1996 . “The good, the bad, and the ugly.” The role of chemokines in models of human disease commentary . J. Immunol. , 156 : 3583 – 3586 .
   PubMed Web of Science ®Google Scholar
• Murphy , P.M. , Baggiolini , M. , Charo , I.F. , Hebert , C.A. , Horuk , R. , Matsushima , K. , Miller , L.H. , Oppenheim , J.J. and Power , C.A. 2000 . International union of pharmacology. XXII. Nomenclature for chemokine receptors . Phamacol. Rev. , 52 : 145 – 176 .
   PubMed Web of Science ®Google Scholar
• Liu , J.Q. and Merritt , J.R. 2010 . CC chemokine receptor small molecule antagonists in the treatment of rheumatoid arthritis and other siseases: A current view . Curr. Top. Med. Chem. , 10 : 1250 – 1267 .
   Web of Science ®Google Scholar
• Gladue , R.P. , Brown , M.F. and Zwillich , S.H. 2010 . CCR1 antagonists: What have we learned from clinical trials . Curr. Top. Med. Chem. , 10 : 1268 – 1277 .
   Web of Science ®Google Scholar
• Pease , J.E. and Horuk , R. 2009 . Chemokine receptor antagonists: Part 1 . Expert. Opin. Ther. Pat. , 19 : 39 – 58 .
   PubMed Web of Science ®Google Scholar
• Pease , J.E. and Horuk , R. 2009 . Chemokine receptor antagonists: Part 2 . Expert. Opin. Ther. Pat. , 19 : 199 – 221 .
   PubMed Web of Science ®Google Scholar
• Naya , A. , Sagara , Y. , Ohwaki , K. , Saeki , T. , Ichikawa , D. , Iwasawa , Y. , Noguchi , K. and Ohtake , N. 2001 . Design, synthesis and discovery of a novel CCR1 antagonist . J. Med. Chem. , 44 : 1429 – 1435 .
   PubMed Web of Science ®Google Scholar
• Naya , A. , Ishikawa , M. , Matsuda , K. , Ohwaki , K. , Saeki , T. , Noguchi , K. and Ohtake , N. 2003 . Structure–activity relationships of xanthene carboxamides, novel CCR1 receptor antagonists . Bioorg. Med. Chem. , 11 : 875 – 884 .
   PubMed Web of Science ®Google Scholar
• Revesz , L. , Bollbuck , B. , Buhl , T. , Eder , J. , Esser , R. , Feifel , R. , Heng , R. , Hiestand , P. , Jachez-Demange , B. , Loetscher , P. , Sparrer , H. , Schlapbach , A. and Waelchli , R. 2005 . Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis . Bioorg. Med. Chem. Lett. , 15 : 5160 – 5164 .
   PubMed Web of Science ®Google Scholar
• Ng , H.P. , May , K. , Bauman , J.G. , Ghannam , A. , Islam , I. , Liang , M. , Horuk , R. , Hesselgesser , J. , Snider , R.M. , Perez , H.D. and Morrissey , M.M. 1999 . Discovery of novel non-peptide CCR1 receptor antagonists . J. Med. Chem. , 42 : 4680 – 4694 .
   PubMed Web of Science ®Google Scholar
• Kath , J.C. , Brissette , W.H. , Brown , M.F. , Conklyn , M. , Difico , A.P. , Dorff , P. , Gladue , R.P. , Lillie , B.M. , Lira , P.D. , Mairs , E.N. , Martin , W.H. , McElroy , E.B. , McGlynn , M.A. , Paradis , T.J. , Poss , C.S. , Stock , I.A. , Tylaska , L.A. and Zheng , D.Y. 2004 . Potent small molecule CCR1 antagonists . Bioorg. Med. Chem. Lett. , 14 : 2169 – 2173 .
   PubMed Web of Science ®Google Scholar
• Xie , Y.F. , Sircar , I. , Lake , K. , Komandla , M. , Ligsay , K. , Li , J. , Xu , K. , Parise , J. , Schneider , L. , Huang , D.Q. , Liu , J.P. , Sakurai , N. , Barbosa , M. and Jack , R. 2008 . Identification of novel series of human CCR1 antagonists . Bioorg. Med. Chem. Lett. , 18 : 2215 – 2221 .
   PubMed Web of Science ®Google Scholar
• Krieger , E. , Nabuurs , S.B. and Vriend , G. 2003 . Homology modeling . Methods Biochem. Anal. , 44 : 509 – 523 .
   PubMedGoogle Scholar
• Patny , A. , Desai , P.V. and Avery , M.A. 2006 . Homology modeling of G-protein-coupled receptors and implications in drug design . Curr. Med. Chem. , 13 : 1667 – 1691 .
   PubMed Web of Science ®Google Scholar
• Palczewski , K. , Kumasaka , T. , Hori , T. , Behnke , C.A. , Motoshima , H. , Fox , B.A. , Le Trong , I. , Teller , D.C. , Okada , T. , Stenkamp , R.E. , Yamamoto , M. and Miyano , M. 2000 . Crystal structure of rhodopsin: A G protein-coupled receptor . Science , 289 : 739 – 745 .
   PubMed Web of Science ®Google Scholar
• Cherezov , V. , Rosenbaum , D.M. , Hanson , M.A. , Rasmussen , S.G. , Thian , F.S. , Kobilka , T. , Choi , H.J. , Kuhn , P. , Weis , W.I. , Kobilka , B.K. and Stevens , R.C. 2007 . High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor . Science , 318 : 1258 – 1265 .
   PubMed Web of Science ®Google Scholar
• Jaakola , V.P. , Griffith , M.T. , Hanson , M.A. , Cherezov , V. , Chien , E.Y.T. , Lane , J.R. , Ijzerman , A.P. and Stevens , R.C. 2008 . The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist . Science , 322 : 1211 – 1217 .
   PubMed Web of Science ®Google Scholar
• Wu , B.L. , Chien , E.Y.T. , Mol , C.D. , Fenalti , G. , Liu , W. , Katritch , V. , Abagyan , R. , Brooun , A. , Wells , P. , Bi , F.C. , Hamel , D.J. , Kuhn , P. , Handel , T.M. , Cherezov , V. and Stevens , R.C. 2010 . Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists . Science , 330 : 1066 – 1071 .
   PubMed Web of Science ®Google Scholar
• Chien , E.Y.T. , Liu , W. , Zhao , Q. , Katritch , V. , Han , G.W. , Hanson , M.A. , Shi , L. , Newman , A.H. , Javitch , J.A. , Cherezov , V. and Stevens , R.C. 2010 . Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist . Science , 330 : 1091 – 1095 .
   PubMed Web of Science ®Google Scholar
• Li , G. , Haney , K.M. , Kellogg , G.E. and Zhang , Y. 2009 . Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models . J. Chem. Inf. Model. , 49 : 120 – 132 .
   PubMed Web of Science ®Google Scholar
• Kneissl , B. , Leonhardt , B. , Hildebrandt , A. and Tautermann , S. 2009 . Revisiting automated G-protein coupled receptor modeling: The benefit of additional template structures for a neurokinin-1 receptor model . J. Med. Chem. , 52 : 3166 – 3173 .
   Web of Science ®Google Scholar
• Kanagarajadurai , K. , Malini , M. , Bhattacharya , A. , Panicker , M.M. and Sowdhamini , R. 2009 . Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding . Mol. BioSyst. , 5 : 1877 – 1888 .
   PubMed Web of Science ®Google Scholar
• McRobb , F.M. , Capuano , B. , Crosby , I.T. , Chalmers , D.K. and Yuriev , E. 2010 . Homology modeling and docking evaluation of aminergic G protein-coupled receptors . J. Chem. Inf. Model. , 50 : 626 – 637 .
   PubMed Web of Science ®Google Scholar
• Dal Ben , D. , Antonini , I. , Buccioni , M. , Lambertucci , C. , Marucci , G. , Vittori , S. , Volpini , R. and Cristalli , G. 2010 . Molecular modeling studies on the human neuropeptide S receptor and its antagonists . ChemMedChem. , 5 : 371 – 383 .
   PubMed Web of Science ®Google Scholar
• Ginalski , K. 2006 . Comparative modeling for protein structure prediction . Curr. Opin. Struc. Biol. , 16 : 172 – 177 .
   PubMed Web of Science ®Google Scholar
• Xiang , Z.X. 2006 . Advances in homology protein structure modeling . Curr. Protein Pept. Sc. , 7 : 217 – 227 .
   PubMed Web of Science ®Google Scholar
• Chenna , R. , Sugawara , H. , Koike , T. , Lopez , R. , Gibson , T.J. , Higgins , D.G. and Thompson , J.D. 2003 . Multiple sequence alignment with the Clustal series of programs . Nucleic Acids Res. , 31 : 3497 – 3500 .
   PubMed Web of Science ®Google Scholar
• Fiser , A. and Sali , A. 2003 . Modeller: Generation and refinement of homology-based protein structure models . Methods Enzymol. , 374 : 461 – 491 .
   PubMed Web of Science ®Google Scholar
• Laskowski , R.A. , MacArthur , M.W. , Moss , D.S. and Thornton , J.M. 1993 . PROCHECK: A program to check the stereochemical quality of protein structures . J. Appl. Crystallogr. , 26 : 283 – 291 .
   Web of Science ®Google Scholar
• Morris , G.M. , Goodsell , D.S. , Halliday , R.S. , Huey , R. , Hart , W.E. , Belew , R.K. and Olson , A.J. 1998 . Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function . J. Comput. Chem. , 19 : 1639 – 1662 .
   Web of Science ®Google Scholar
• Forrest , L.R. , Tang , C.L. and Honig , B. 2006 . On the accuracy of homology modeling and sequence alignment methods applied to membrane proteins . Biophys. J. , 91 : 508 – 517 .
   PubMed Web of Science ®Google Scholar
• Liao , Q.H. , Gao , Q.Z. , Wei , J. and Chou , K.C. 2011 . Docking and molecular dynamics study on the inhibitory activity of novel inhibitors on epidermal growth factor receptor (EGFR) . Med. Chem. , 7 : 24 – 31 .
   PubMed Web of Science ®Google Scholar
• Wei , J. , Li , H. , Qu , W. and Gao , Q.Z. 2009 . Molecular docking study of A3 adenosine receptor antagonists and pharmacophore-based drug design . Neurochem. Int. , 55 : 637 – 642 .
   PubMed Web of Science ®Google Scholar
• Housaindokht , M.R. , Bozorgmehr , M.R. and Bahrololoom , M. 2008 . Analysis of ligand binding to proteins using molecular dynamics simulations . J. Theor. Biol. , 254 : 294 – 300 .
   PubMed Web of Science ®Google Scholar
• Wang , J.F. , Wei , D.Q. , Li , L. , Zheng , S.Y. , Li , Y.X. and Chou , K.C. 2007 . 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design . Biochem. Biophy. Res. Co. , 355 : 513 – 519 .
   PubMed Web of Science ®Google Scholar
• Liu , Y.X. , Andre , P. , Wei , J. and Zhao , K. 2009 . 3D-pharmacophere models for CC chemokine receptor 1 antagonists . Med. Chem. , 5 : 318 – 324 .
   Web of Science ®Google Scholar
• de Mendonca , F.L. , da Fonseca , P.C.A. , Phillips , R.M. , Saldanha , J.W. , Williams , T.J. and Pease , J.E. 2005 . Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist . J. Biol. Chem. , 280 : 4808 – 4816 .
   PubMed Web of Science ®Google Scholar